-
Loading metrics
Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms
- Kangsadan Chueajedton,
- Chaiwat Chueaiphuk,
- Jeranan Inpad,
- Sarawut Kumphune,
- Worasak Kaewkong,
- Damratsamon Surangkul,
- Kanlayanee Sawanyawisuth,
- Ubon Cha’on,
- Suchada Phimsen
x
- Published: January 20, 2026
- https://doi.org/10.1371/journal.pone.0340763